Showing results (1461-1470 of 1,557) with videos related to
Sort By:
Pageof 156
Cancer Research|July 28, 2011
A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitorsTakaaki Sasaki, Jussi Koivunen, Atsuko Ogino, et al.ACS Chemical Biology|February 22, 2014
Discovery of a potent, covalent BTK inhibitor for B-cell lymphomaHong Wu, Wenchao Wang, Feiyang Liu, et al.Cell Chemical Biology|March 10, 2026
A small molecule PTER-selective inhibitor reduces food intake and body weightSipei Fu, Lushun Wang, Veronica L Li, et al.Science Advances|September 12, 2020
CDK13 cooperates with CDK12 to control global RNA polymerase II processivityZheng Fan, Jennifer R Devlin, Simon J Hogg, et al.Cancer Discovery|May 4, 2021
Inhibition of CDK4/6 Promotes CD8 T-cell Memory FormationMax Heckler, Lestat R Ali, Eleanor Clancy-Thompson, et al.Proceedings of the National Academy of Sciences of the United States of America|October 29, 2014
Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitorsLi Tan, Jun Wang, Junko Tanizaki, et al.Neuro-Oncology|January 14, 2017
A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomasYu Sun, John A Alberta, Catherine Pilarz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2020
Circulating Tumor DNA Predicts Outcome from First-, but not Second-line Treatment and Identifies Melanoma Patients Who May Benefit from Combination ImmunotherapyGabriela Marsavela, Jenny Lee, Leslie Calapre, et al.Biorxiv : the Preprint Server for Biology|February 9, 2026
A small molecule PTER-selective inhibitor reduces food intake and body weightSipei Fu, Lushun Wang, Veronica L Li, et al.Cell Chemical Biology|March 5, 2020
Targeting the PI5P4K Lipid Kinase Family in Cancer Using Covalent InhibitorsSindhu Carmen Sivakumaren, Hyeseok Shim, Tinghu Zhang, et al.Pageof 156